Titre : Anciens combattants

Anciens combattants : Questions médicales fréquentes

Termes MeSH sélectionnés :

Administration, Intravenous
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Anciens combattants : Questions médicales les plus fréquentes", "headline": "Anciens combattants : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Anciens combattants : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-20", "dateModified": "2025-03-17", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Anciens combattants" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Personnes", "url": "https://questionsmedicales.fr/mesh/D009272", "about": { "@type": "MedicalCondition", "name": "Personnes", "code": { "@type": "MedicalCode", "code": "D009272", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "M01" } } }, "about": { "@type": "MedicalCondition", "name": "Anciens combattants", "alternateName": "Veterans", "code": { "@type": "MedicalCode", "code": "D014728", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Megan E Vanneman", "url": "https://questionsmedicales.fr/author/Megan%20E%20Vanneman", "affiliation": { "@type": "Organization", "name": "Informatics, Decision-Enhancement and Analytic Sciences Center, Veterans Affairs Salt Lake City Health Care System, Salt Lake City, Utah." } }, { "@type": "Person", "name": "Jean Yoon", "url": "https://questionsmedicales.fr/author/Jean%20Yoon", "affiliation": { "@type": "Organization", "name": "Health Economics Resource Center, Veterans Affairs Palo Alto Health Care System, Menlo Park, California." } }, { "@type": "Person", "name": "Ryan Holliday", "url": "https://questionsmedicales.fr/author/Ryan%20Holliday", "affiliation": { "@type": "Organization", "name": "Rocky Mountain Mental Illness Research, Education, and Clinical Center for Suicide Prevention, Aurora, CO, USA." } }, { "@type": "Person", "name": "Elizabeth M Yano", "url": "https://questionsmedicales.fr/author/Elizabeth%20M%20Yano", "affiliation": { "@type": "Organization", "name": "VA HSR&D Center for the Study of Healthcare Innovation, Implementation and Policy (CSHIIP), VA Greater Los Angeles Healthcare System, Los Angeles, California; Department of Health Policy and Management, Fielding School of Public Health, University of California Los Angeles, Los Angeles, California." } }, { "@type": "Person", "name": "John C Fortney", "url": "https://questionsmedicales.fr/author/John%20C%20Fortney", "affiliation": { "@type": "Organization", "name": "Meadows Mental Health Policy Institute, Dallas, and Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago (Carlo); VA Puget Sound Healthcare System, U.S. Department of Veterans Affairs (VA), Seattle (Sterling, Mao, Fortney, Wong); Earth and Environmental Sciences Division, Los Alamos National Laboratory, Los Alamos, New Mexico (Fiorella); Departments of Psychiatry and Behavioral Sciences (Fortney, Unützer) and Health Systems and Population Health (Wong), School of Medicine, University of Washington, Seattle." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Efficacy and feasibility of scheduled intravenous acetaminophen administration after pancreatoduodenectomy: a propensity score-matched study.", "datePublished": "2023-02-06", "url": "https://questionsmedicales.fr/article/36746797", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00595-023-02647-3" } }, { "@type": "ScholarlyArticle", "name": "Safety findings after intravenous administration of sulfur hexafluoride microbubbles to 463,434 examinations at 24 centers.", "datePublished": "2022-10-07", "url": "https://questionsmedicales.fr/article/36205769", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00330-022-09108-4" } }, { "@type": "ScholarlyArticle", "name": "Development of Therapeutic Proteins for a New Subcutaneous Route of Administration After the Establishment of Intravenous Dosages: A Systematic Review.", "datePublished": "2023-01-09", "url": "https://questionsmedicales.fr/article/36516352", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/cpt.2823" } }, { "@type": "ScholarlyArticle", "name": "Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosis.", "datePublished": "2023-01-13", "url": "https://questionsmedicales.fr/article/36639226", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/jnnp-2022-330467" } }, { "@type": "ScholarlyArticle", "name": "Temporal trends of post-contrast acute kidney injury in patients with intravenous administration of iodinated contrast medium.", "datePublished": "2023-09-19", "url": "https://questionsmedicales.fr/article/37724551", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/0886022X.2023.2251588" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Personnes", "item": "https://questionsmedicales.fr/mesh/D009272" }, { "@type": "ListItem", "position": 3, "name": "Anciens combattants", "item": "https://questionsmedicales.fr/mesh/D014728" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Anciens combattants - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Anciens combattants", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Anciens combattants", "description": "Comment diagnostiquer le stress post-traumatique chez un vétéran ?\nQuels tests sont utilisés pour évaluer la santé mentale des anciens combattants ?\nComment détecter les troubles de l'humeur chez les vétérans ?\nQuels signes indiquent une maladie physique chez un ancien combattant ?\nComment évaluer les risques de dépendance chez les vétérans ?", "url": "https://questionsmedicales.fr/mesh/D014728?mesh_terms=Administration,+Intravenous&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Anciens combattants", "description": "Quels sont les symptômes du stress post-traumatique ?\nComment se manifestent les troubles de l'humeur chez les vétérans ?\nQuels symptômes physiques sont fréquents chez les anciens combattants ?\nQuels signes indiquent une dépendance chez un vétéran ?\nComment reconnaître l'anxiété chez un ancien combattant ?", "url": "https://questionsmedicales.fr/mesh/D014728?mesh_terms=Administration,+Intravenous&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Anciens combattants", "description": "Comment prévenir le stress post-traumatique chez les vétérans ?\nQuelles mesures peuvent réduire les risques de dépression ?\nComment favoriser la santé mentale des anciens combattants ?\nQuelles stratégies aident à prévenir la dépendance ?\nComment promouvoir le bien-être physique chez les vétérans ?", "url": "https://questionsmedicales.fr/mesh/D014728?mesh_terms=Administration,+Intravenous&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Anciens combattants", "description": "Quels traitements sont efficaces pour le stress post-traumatique ?\nComment traiter la dépression chez les anciens combattants ?\nQuelles approches sont utilisées pour la gestion de la douleur ?\nQuels sont les traitements pour les troubles de l'humeur ?\nComment aborder la dépendance chez les vétérans ?", "url": "https://questionsmedicales.fr/mesh/D014728?mesh_terms=Administration,+Intravenous&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Anciens combattants", "description": "Quelles complications peuvent survenir avec le stress post-traumatique ?\nComment la dépression peut-elle affecter la vie quotidienne ?\nQuelles sont les conséquences d'une douleur chronique non traitée ?\nQuels risques sont associés à la dépendance chez les vétérans ?\nComment le stress peut-il affecter la santé physique ?", "url": "https://questionsmedicales.fr/mesh/D014728?mesh_terms=Administration,+Intravenous&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Anciens combattants", "description": "Quels facteurs augmentent le risque de stress post-traumatique ?\nComment l'isolement social influence-t-il la santé mentale ?\nQuels antécédents médicaux sont des facteurs de risque pour les vétérans ?\nComment le stress au travail affecte-t-il les vétérans ?\nQuels rôles jouent les facteurs environnementaux dans la santé des vétérans ?", "url": "https://questionsmedicales.fr/mesh/D014728?mesh_terms=Administration,+Intravenous&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer le stress post-traumatique chez un vétéran ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des entretiens cliniques et des critères DSM-5." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer la santé mentale des anciens combattants ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des échelles d'évaluation comme le PCL-5 et des entretiens cliniques sont utilisés." } }, { "@type": "Question", "name": "Comment détecter les troubles de l'humeur chez les vétérans ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "L'évaluation clinique et les questionnaires standardisés aident à identifier ces troubles." } }, { "@type": "Question", "name": "Quels signes indiquent une maladie physique chez un ancien combattant ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs chroniques, des troubles respiratoires ou des problèmes cardiaques peuvent indiquer une maladie." } }, { "@type": "Question", "name": "Comment évaluer les risques de dépendance chez les vétérans ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des questionnaires sur l'usage de substances et des entretiens cliniques sont utilisés." } }, { "@type": "Question", "name": "Quels sont les symptômes du stress post-traumatique ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des flashbacks, l'anxiété, et l'évitement de situations rappelant le traumatisme." } }, { "@type": "Question", "name": "Comment se manifestent les troubles de l'humeur chez les vétérans ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent se manifester par la dépression, l'irritabilité et des sautes d'humeur fréquentes." } }, { "@type": "Question", "name": "Quels symptômes physiques sont fréquents chez les anciens combattants ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs chroniques, des troubles digestifs et des problèmes respiratoires sont courants." } }, { "@type": "Question", "name": "Quels signes indiquent une dépendance chez un vétéran ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des changements de comportement, l'isolement social et des problèmes de santé peuvent indiquer une dépendance." } }, { "@type": "Question", "name": "Comment reconnaître l'anxiété chez un ancien combattant ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "L'anxiété se manifeste par des palpitations, des tremblements et une inquiétude excessive." } }, { "@type": "Question", "name": "Comment prévenir le stress post-traumatique chez les vétérans ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Des programmes de soutien psychologique et des formations sur la gestion du stress sont essentiels." } }, { "@type": "Question", "name": "Quelles mesures peuvent réduire les risques de dépression ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Encourager le soutien social et l'activité physique peut aider à réduire les risques." } }, { "@type": "Question", "name": "Comment favoriser la santé mentale des anciens combattants ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Des programmes de sensibilisation et d'accès aux soins de santé mentale sont cruciaux." } }, { "@type": "Question", "name": "Quelles stratégies aident à prévenir la dépendance ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation sur les risques et le soutien communautaire sont des stratégies efficaces." } }, { "@type": "Question", "name": "Comment promouvoir le bien-être physique chez les vétérans ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Encourager l'exercice régulier et une alimentation équilibrée contribue au bien-être physique." } }, { "@type": "Question", "name": "Quels traitements sont efficaces pour le stress post-traumatique ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie cognitivo-comportementale et les médicaments comme les ISRS sont efficaces." } }, { "@type": "Question", "name": "Comment traiter la dépression chez les anciens combattants ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les antidépresseurs et la psychothérapie sont couramment utilisés pour traiter la dépression." } }, { "@type": "Question", "name": "Quelles approches sont utilisées pour la gestion de la douleur ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la médication, la physiothérapie et des techniques de relaxation." } }, { "@type": "Question", "name": "Quels sont les traitements pour les troubles de l'humeur ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la thérapie, les médicaments et des programmes de soutien." } }, { "@type": "Question", "name": "Comment aborder la dépendance chez les vétérans ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les programmes de désintoxication et la thérapie de groupe sont des approches efficaces." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec le stress post-traumatique ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles de l'humeur, des problèmes de santé physique et des comportements suicidaires peuvent survenir." } }, { "@type": "Question", "name": "Comment la dépression peut-elle affecter la vie quotidienne ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut entraîner des difficultés relationnelles, des problèmes de travail et une baisse de la qualité de vie." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une douleur chronique non traitée ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut mener à l'anxiété, à la dépression et à une diminution de la mobilité." } }, { "@type": "Question", "name": "Quels risques sont associés à la dépendance chez les vétérans ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les risques incluent des problèmes de santé, des conflits relationnels et des comportements criminels." } }, { "@type": "Question", "name": "Comment le stress peut-il affecter la santé physique ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Le stress chronique peut entraîner des maladies cardiovasculaires, des troubles digestifs et d'autres problèmes de santé." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de stress post-traumatique ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les expériences de combat, le soutien social faible et des antécédents de troubles mentaux augmentent le risque." } }, { "@type": "Question", "name": "Comment l'isolement social influence-t-il la santé mentale ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "L'isolement social peut aggraver les symptômes de dépression et d'anxiété chez les vétérans." } }, { "@type": "Question", "name": "Quels antécédents médicaux sont des facteurs de risque pour les vétérans ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Des antécédents de troubles mentaux ou de blessures physiques augmentent les risques de complications." } }, { "@type": "Question", "name": "Comment le stress au travail affecte-t-il les vétérans ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Le stress au travail peut exacerber les troubles mentaux et physiques chez les anciens combattants." } }, { "@type": "Question", "name": "Quels rôles jouent les facteurs environnementaux dans la santé des vétérans ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs environnementaux, comme l'exposition à des toxines, peuvent affecter la santé physique et mentale." } } ] } ] }

Sources (10000 au total)

Efficacy and feasibility of scheduled intravenous acetaminophen administration after pancreatoduodenectomy: a propensity score-matched study.

The efficiency and safety of routine intravenous administration of acetaminophen after highly invasive hepatobiliary pancreatic surgery remain unclear. In particular, there have been no studies focusi... We retrospectively collected 179 patients who underwent open pancreatoduodenectomy from 2015 to 2020. The analgesic effects and adverse events in patients with scheduled intravenous administration of ... After 40 patients from each group were selected by propensity score matching, the postoperative liver function tests were not significantly different between the control and acetaminophen groups. No s... The scheduled intravenous administration of acetaminophen did not affect the postoperative liver function and had a good analgesic effect after pancreatoduodenectomy....

Safety findings after intravenous administration of sulfur hexafluoride microbubbles to 463,434 examinations at 24 centers.

We aimed to evaluate the safety of the ultrasound contrast agent sulfur hexafluoride microbubbles in a large group of patients referred for routine contrast-enhanced ultrasound (CEUS).... A retrospective assessment was made of all patients that received sulfur hexafluoride microbubbles intravenously for CEUS at 24 centers between January 2006 and April 2019. Patient demographic details... A total of 463,434 examinations were evaluated. Overall, 157 AEs (153 [0.033%] non-serious; 4 [0.001%] serious) were reported after sulfur hexafluoride microbubbles administration, giving an AE freque... The frequency of AEs to sulfur hexafluoride microbubbles is very low and severe reactions are rare, confirming that sulfur hexafluoride microbubbles are appropriate for routine CEUS applications.... • The frequency of AEs to sulfur hexafluoride microbubbles is very low and severe reactions are rare....

Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosis.

Natalizumab is effective in the treatment of multiple sclerosis (MS). In 2021, the European Medicines Agency approved the subcutaneous (SC) variant of natalizumab which can be used instead of intraven... The NEXT-MS trial (N=382) investigates personalised treatment of natalizumab, in which infusion intervals are prolonged based on individual natalizumab trough drug levels. In 2021, an amendment was ap... Until December 2022, 15 participants switched to SC natalizumab. Natalizumab drug levels with SC administration were on average 55% lower compared with intravenous administration (Exp (estimate) 0.45,... Natalizumab trough drug levels can decrease after switching from natalizumab intravenous to SC administration. We advise to monitor trough drug levels in patients with low natalizumab drug levels duri...

Intravenous iron administration before cardiac surgery reduces red blood cell transfusion in patients without anaemia.

Reducing the need for blood transfusion among patients undergoing cardiac surgery FLA reduce postoperative complications and mortality. Our study aimed to assess the effects of administering preoperat... This double-blind, randomised, placebo-controlled trial was conducted between October 2016 and November 2019, with a follow-up period of up to 6 weeks after surgery. Patients without anaemia who under... The 200 patients included were randomly assigned to the ferric carboxymaltose (n=102) and placebo (n=98) groups. By postoperative Day 4, a significantly lower mean number of red cell units were transf... In patients without anaemia undergoing on-pump cardiac surgery, treatment with a single dose of 1000 mg ferric carboxymaltose i.v. 1-3 days before surgery significantly reduced the need for red cell t... NCT02939794....

Ciprofloxacin Pharmacokinetics After Oral and Intravenous Administration in (Morbidly) Obese and Non-obese Individuals: A Prospective Clinical Study.

Ciprofloxacin is a fluoroquinolone used for empirical and targeted therapy of a wide range of infections. Despite the increase in obesity prevalence, only very limited guidance is available on whether... (Morbidly) obese individuals undergoing bariatric surgery received ciprofloxacin either orally (500 mg; n = 10) or intravenously (400 mg; n = 10), while non-obese participants received semi-simultaneo... Overall, 28 participants with body weights ranging from 57 to 212 kg were recruited. No significant influence of body weight on bioavailability, clearance or volume of distribution was identified (all... Based on plasma pharmacokinetics, we found no evidence of the influence of obesity on ciprofloxacin pharmacokinetic parameters; therefore, ciprofloxacin dosages do not need to be increased routinely i... Registered in the Dutch Trial Registry (NTR6058)....